Diaphorina citri psyllid: psy17306


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900----
MNDIAQLGIGLLELAHREYQAGDYESAERHCMQLWRQETNNTGVLLLLSSIHFQCRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPDLYCVRSDLGNLLKALGRLDEAKDLYCVRSDLGNLLKALGRLDEAKNLHTENIKPVTMKVQNAIVCNYGGRKPTTLESAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPLLKKEDGWNTEPFVLDFERRKALWRRGALVMMKRPVLGLASAIESISANQEKCAVNIKIECASKDLHSGLFGGSVHEAMTDLIYIMGQLVEPNGKILIPHIYKDVEPLGDTEEQFYEKIDFDTEDFRTAIDHPKLTKADKTQVLMSRWRYPSLSLHGIEGAFSGPGGKTVIPGKVVGKFSIRIVPNQTPQCVEKYVLDYLNELWKARNSPNKFKAYLLDSGKSWRTNPEHPNYVAAARATKYVYNVEPDLTREGGSIPITLTFECRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPSCYLKAIETRPDFAVAWSNLGCVFNAQGEIWLAIHHFEKAVSLDPNFLDAYINLGNVLKEARIFDRANTLFYVSSYFMITDEDIDVILERCEAKTEELNKKFEQLGESSLRDFTLDAPTQSVYKFEGEDYREKQKIVPIGHWIEPPKRERKANYAVDAYFKEALRTSEPKAPKAPRPPKQPIVQDFQFFPPRLFEILDQEIYYFRKTVGYKVPKNPELGSDATKAQKEEQKKIDESEPLTEEELAEKEELLTQF
ccccccHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHcccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccHHcccHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHcccccccccccccHHHcccccHHHHHHHHcccccHHHHHHHcccccHHHHHHHHHHHHccccccccccccHccccccccccccccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccHHHHcccccCEEccccccHHHHHHHHHHHHHHcccccHHHccccHHHHHHHccccHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHccHHHHHccccccccccccccHHHHHHcccHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHccccccccHHHHHHHHHHHHcc
*NDIAQLGIGLLELAHREYQAGDYESAERHCMQLWRQETNNTGVLLLLSSIHFQCRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPDLYCVRSDLGNLLKALGRLDEAKDLYCVRSDLGNLLKALGRLDEAKNLHTENIKPVTMKVQNAIVCNYGGRKPTTLESAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPLLKKEDGWNTEPFVLDFERRKALWRRGALVMMKRPVLGLASAIESISANQEKCAVNIKIECASKDLHSGLFGGSVHEAMTDLIYIMGQLVEPNGKILIPHIYKDVEPLGDTEEQFYEKIDFDTEDFRTAIDHPKLTKADKTQVLMSRWRYPSLSLHGIEGAFSGPGGKTVIPGKVVGKFSIRIVPNQTPQCVEKYVLDYLNELWKARNSPNKFKAYLLDSGKSWRTNPEHPNYVAAARATKYVYNVEPDLTREGGSIPITLTFECRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPSCYLKAIETRPDFAVAWSNLGCVFNAQGEIWLAIHHFEKAVSLDPNFLDAYINLGNVLKEARIFDRANTLFYVSSYFMITDEDIDVILERCEAKTEELNKKFEQLGESSLRDFTLDAPTQSVYKFEGEDYREKQKIVPIGHWIEPPKRERKANYAVDAYFKEAL*****************IVQDFQFFPPRLFEILDQEIYYFRKTVGYKVP***********************************EL**Q*
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNDIAQLGIGLLELAHREYQAGDYESAERHCMQLWRQETNNTGVLLLLSSIHFQCRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPDLYCVRSDLGNLLKALGRLDEAKDLYCVRSDLGNLLKALGRLDEAKNLHTENIKPVTMKVQNAIVCNYGGRKPTTLESAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPLLKKEDGWNTEPFVLDFERRKALWRRGALVMMKRPVLGLASAIESISANQEKCAVNIKIECASKDLHSGLFGGSVHEAMTDLIYIMGQLVEPNGKILIPHIYKDVEPLGDTEEQFYEKIDFDTEDFRTAIDHPKLTKADKTQVLMSRWRYPSLSLHGIEGAFSGPGGKTVIPGKVVGKFSIRIVPNQTPQCVEKYVLDYLNELWKARNSPNKFKAYLLDSGKSWRTNPEHPNYVAAARATKYVYNVEPDLTREGGSIPITLTFECRKLDKSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEALENYRHAVRLKPDFIDGYINLAAALVAAGDMEQAVQAYVTALQYNPSCYLKAIETRPDFAVAWSNLGCVFNAQGEIWLAIHHFEKAVSLDPNFLDAYINLGNVLKEARIFDRANTLFYVSSYFMITDEDIDVIxxxxxxxxxxxxxxxxxxxxxSLRDFTLDAPTQSVYKFEGEDYREKQKIVPIGHWIEPPKRERKANYAVDAYFKEALRTSEPKAPKAPRPPKQPIVQDFQFFPPRLFEILDQEIYYFRKTVGYKVPKNPELGSDATKAQKEEQKKIDESEPLTEEELAEKEELLTQF

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Cys-Gly metallodipeptidase dug1 Catalytic component of the GSH degradosomal complex involved in the degradation of glutathione (GSH) and other peptides containing a gamma-glu-X bond. Has a Gly-Cys dipeptidase activity.confidentQ9P6I2

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0030854 [BP]positive regulation of granulocyte differentiationprobableGO:0002761, GO:1902107, GO:0002763, GO:0051094, GO:0050793, GO:0065007, GO:0045597, GO:0045595, GO:0050794, GO:0030852, GO:0050789, GO:1902105, GO:0045639, GO:0002682, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0045637, GO:0048522
GO:0006110 [BP]regulation of glycolysisprobableGO:0043470, GO:0043471, GO:0043467, GO:0031329, GO:0060255, GO:0031323, GO:0009894, GO:0050794, GO:0010906, GO:0065007, GO:0010675, GO:0008150, GO:0019222, GO:0006109, GO:0050789, GO:0080090
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0006749 [BP]glutathione metabolic processprobableGO:0044238, GO:0044710, GO:0009987, GO:1901564, GO:0006575, GO:0043603, GO:0006082, GO:0006520, GO:0044237, GO:0071704, GO:0034641, GO:0006807, GO:0006790, GO:0019752, GO:0008152, GO:0043436, GO:0008150, GO:0006518, GO:0044281
GO:0035020 [BP]regulation of Rac protein signal transductionprobableGO:0051056, GO:0009966, GO:0048583, GO:0046578, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0005739 [CC]mitochondrionprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0005840 [CC]ribosomeprobableGO:0005737, GO:0032991, GO:0043232, GO:0044464, GO:0043229, GO:0005623, GO:0030529, GO:0005575, GO:0044444, GO:0043228, GO:0044424, GO:0005622, GO:0043226
GO:0045862 [BP]positive regulation of proteolysisprobableGO:0009893, GO:0032268, GO:0080090, GO:0019222, GO:0060255, GO:0031323, GO:0031325, GO:0051246, GO:0051247, GO:0050794, GO:0008150, GO:0065007, GO:0030162, GO:0048518, GO:0032270, GO:0010604, GO:0050789, GO:0048522
GO:0046626 [BP]regulation of insulin receptor signaling pathwayprobableGO:0009966, GO:1900076, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0008238 [MF]exopeptidase activityprobableGO:0016787, GO:0008233, GO:0070011, GO:0003674, GO:0003824
GO:0043995 [MF]histone acetyltransferase activity (H4-K5 specific)probableGO:0008080, GO:0004402, GO:0016740, GO:0003824, GO:0016407, GO:0016746, GO:0016747, GO:0016410, GO:0003674, GO:0010485
GO:0043996 [MF]histone acetyltransferase activity (H4-K8 specific)probableGO:0008080, GO:0004402, GO:0016740, GO:0003824, GO:0016407, GO:0016746, GO:0016747, GO:0016410, GO:0003674, GO:0010485
GO:0032868 [BP]response to insulin stimulusprobableGO:1901700, GO:0009719, GO:0050896, GO:0009725, GO:0010243, GO:1901698, GO:0008150, GO:1901652, GO:0042221, GO:0043434, GO:0010033
GO:0005886 [CC]plasma membraneprobableGO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623
GO:0000123 [CC]histone acetyltransferase complexprobableGO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0051571 [BP]positive regulation of histone H3-K4 methylationprobableGO:0033044, GO:0009893, GO:0019222, GO:0033043, GO:0031325, GO:0031323, GO:0051128, GO:0051569, GO:0031056, GO:0031058, GO:0050789, GO:0080090, GO:0010604, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0051130, GO:0060255, GO:0050794, GO:0031060, GO:0031062, GO:0032268, GO:0031401, GO:0010638, GO:0008150, GO:2001252, GO:0048522
GO:0008047 [MF]enzyme activator activityprobableGO:0030234, GO:0003674
GO:0005576 [CC]extracellular regionprobableGO:0005575
GO:0046972 [MF]histone acetyltransferase activity (H4-K16 specific)probableGO:0008080, GO:0004402, GO:0016740, GO:0003824, GO:0016407, GO:0016746, GO:0016747, GO:0016410, GO:0003674, GO:0010485
GO:0005547 [MF]phosphatidylinositol-3,4,5-trisphosphate bindingprobableGO:0043168, GO:0035091, GO:0005543, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:1901981
GO:0005813 [CC]centrosomeprobableGO:0005856, GO:0005575, GO:0015630, GO:0043232, GO:0044464, GO:0005623, GO:0005815, GO:0044446, GO:0043229, GO:0043228, GO:0044430, GO:0044424, GO:0005622, GO:0043226, GO:0044422
GO:0048015 [BP]phosphatidylinositol-mediated signalingprobableGO:0044700, GO:0051716, GO:0044699, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0050789, GO:0048017
GO:0070688 [CC]MLL5-L complexprobableGO:0031974, GO:0043229, GO:0005623, GO:0043227, GO:0043226, GO:0034708, GO:0005575, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0035097, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0044424, GO:0044422
GO:0071300 [BP]cellular response to retinoic acidprobableGO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 1W3B, chain A
Confidence level:very confident
Coverage over the Query: 12-167,224-302,541-565,577-640,652-713
View the alignment between query and template
View the model in PyMOL
Template: 1W3B, chain A
Confidence level:very confident
Coverage over the Query: 47-167,224-302,541-565,577-640,652-744
View the alignment between query and template
View the model in PyMOL
Template: 2XPI, chain A
Confidence level:very confident
Coverage over the Query: 7-192,226-302,373-387,418-431,526-531,542-565,577-742
View the alignment between query and template
View the model in PyMOL
Template: 2GW1, chain A
Confidence level:very confident
Coverage over the Query: 41-166,196-302,541-565,577-640,652-758
View the alignment between query and template
View the model in PyMOL
Template: 1OFC, chain X
Confidence level:very confident
Coverage over the Query: 805-903
View the alignment between query and template
View the model in PyMOL
Template: 3DLJ, chain A
Confidence level:very confident
Coverage over the Query: 352-563
View the alignment between query and template
View the model in PyMOL
Template: 3KHX, chain A
Confidence level:probable
Coverage over the Query: 305-551
View the alignment between query and template
View the model in PyMOL